Insider filing · ADMA
Brad L. Tade
CFO and Treasurer
profile →
ADMA Biologics, Inc.
ADMA · Healthcare · 23 filings in 24 months
ticker →
Brad L. Tade sold $317K of ADMA Biologics (ADMA)
Executed Nov 22 2024, disclosed Nov 22 2024, the same day.
Value, as filed
$317K
15,000 sh × $21.15
Executed
Nov 22 2024
the trade date, as filed
Disclosed
Nov 22 2024
0 days after the trade
Return, 21 sessionsiFrom the disclosed entry session; derived
–
purchases only
Returns are measured on stock purchases only.
The filer
BTBrad L. Tade (CFO and Treasurer) filed 1 Form 4 report in the past 24 months (0 purchases, 1 sale), most often in ADMA Biologics, Inc. (ADMA). The largest single filing was $317K of ADMA (15,000 sh × $21.15, as filed), executed Nov 22 2024.
The name
ADMAHealthcare · ADMA Biologics, Inc., a biopharmaceutical company, develops, manufactures, and markets specialty plasma-derived biologics for the treatment…
More Healthcare filings→ Insider filings, newest first→ View the original filing at www.sec.gov→